Biologically, these adenocarcinomas differ greatly from adenocarcinomas seen in ever smokers, with differences in the proportion of oncogenic driver mutations such as EGFR, KRAS, and BRAF [9,10,11]; these seem to predominate in never smokers, females, and those of east Asian descent [10,12]. Here, KRAS is linked to adenocarcinoma.